Conclusions
As inflammation is becoming increasingly viewed as a major and independent risk factor for cardiovascular disease, longstanding models of atherosclerosis and vascular injury must now be evaluated in the context of those pathological features that develop in response to inflammation. It is quite possible that our understanding of existing therapies is about to change dramatically, when the concept of vascular inflammation is overlaid onto the progression of cardiovascular disease. Perhaps an agent as old as aspirin with its bona fide benefit in cardiovascular disease will experience a shift in the attribution of its pharmacological effects, where the anti-inflammatory effects become equally important for cardiovascular disease as the effects on platelet cyclooxygenase.
For preclinical models to be of predictive value in human disease, there must be reasonable parity of biological pathways between man and lower vertebrates. Such may be the case with elements of biology that are highly homologous across mammalian species such as norepinehrine and adrenergic receptors or heparin and anticoagulation, where strong ties have been established between preclinical and clinical pharmacology. The inflammatory process and the immune system operate in a very complex system of activating and attenuating signals, many of which are biologicals that are only partially understood or have yet to be discovered. Further, the parity between the inflammation and immune pathways between man and preclinically tested species may not be as strong as in other areas of biology. While the contribution of inflammation to vascular disease has been recognized, our ability to thoroughly understand its contribution is currently hindered, but no doubt will improve as technology improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ross R, Glomset J, Harker L (1977) Response to injury and atherogenesis. Am J Pathol 86(3): 675–684
Kraiss LW, Clowes AW (1997) Response of the arterial wall to injury and intimal hyperplasia. In: A Sidawy, B Sumpio, R DePalma (eds): The Basic Science of Vascular Disease. Armonk, New York, 289–317
Ross R (1999) Atherosclerosis — an inflammatory disease. N Engl J Med 340(2):115–126
Libby P (2001) Inflammation in atherosclerosis. Nature 420(6917): 868–874
Glass CK, Witztum JL (2001) Atherosclerosis. The road ahead. Cell 104(4): 503–516
Muller JE, Tofler GH (1992) Triggering and hourly variation of onset of arterial thrombosis. Ann Epidemiol 2(4): 393–405
Virmani R, Burke AP, Kolodgie FD, Farb A (2003) Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 16(3): 267–272
Shah PK (2003) Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 41(4 Suppl S): 15S–22S
Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94(6): 2493–2503
Carmeliet P (2000) Proteinases in cardiovascular aneurysms and rupture: targets for therapy? J Clin Invest 105(11): 1519–1520
O’Keefe JH Jr, Conn RD, Lavie CJ, Bateman TM (1996) The new paradigm for coronary artery disease: altering risk factors, atherosclerotic plaques, and clinical prognosis. Mayo Clin Proc 71(10): 957–965
Shah PK (1996) Pathophysiology of plaque rupture and the concept of plaque stabilization. Cardiol Clin 14(1): 17–29
MacIsaac AI, Thomas JD, Topol EJ (1993) Toward the quiescent coronary plaque. J Am Coll Cardiol 22(4): 1228–1241
Forrester JS (2002) Prevention of plaque rupture: a new paradigm of therapy. Ann Intern Med 137(10): 823–833
Ambrose JA, Martinez EE (2002) A new paradigm for plaque stabilization. Circulation 105(16): 2000–2004
Ross R (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57: 791–804
Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT (1996) Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 347(9013):1447–1451
Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, Stefanadi E, Toutouzas P (1999) Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation 99(15): 1965–1971
Liuzzo G, Kopecky SL, Frye RL, O’Fallon WM, Maseri A, Goronzy JJ, Weyand CM (1999) Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100(21): 2135–2139
Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2002) T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105(5): 570–575
Madjid M, Awan I, Willerson JT, Casscells SW (2004) Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44(10):1945–1956
Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES (2005) Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 96(7): 714–716
van den Berg CW, Taylor KE (2005) Letter in response to Bisoendial et al: “Activation of inflammation and coagulation after infusion of C-reactive protein in humans”. Circ Res 97(1): e2
Jawien J, Nastalek P, Korbut R (2004) Mouse models of experimental atherosclerosis. J Physiol Pharmacol 55(3): 503–517
Yanni AE (2004) The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 38(3): 246–256
Meir KS, Leitersdorf E (2004) Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24(6): 1006–1014
Dal Canto AJ, Virgin HW (2000) Animal models of infection-mediated vasculitis: implications for human disease. Int J Cardiol 75(Suppl 1): S37–45; discussion S47–52
Moyer CF, Reinisch CL (1989) Vasculitis in MRL/1 pr mice: model of cell-mediated autoimmunity. Toxicol Pathol 17(1 Pt 2): 122–128
Stemerman MB, Spaet TH, Pitlick F, Cintron J, Lejnieks I, Tiell ML (1977) Intimal healing. The pattern of reendothelialization and intimal thickening. Am J Pathol 87(1):125–142
Clowes AW, Reidy MA, Clowes MM (1983) Mechanisms of stenosis after arterial injury. Lab Invest 49(2): 208–215
Jahnke T, Karbe U, Schafer FK, Bolte H, Heuer G, Rector L, Brossmann J, Heller M, Muller-Hulsbeck S (2005) Characterization of a new double-injury restenosis model in the rat aorta. J Endovasc Ther 12(3): 318–331
Courtman DW, Schwartz SM, Hart CE (1998) Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass: extrinsic pathway inhibition eliminates luminal narrowing. Circ Res 82(9):996–1006
De Leon H, Ollerenshaw JD, Griendling KK, Wilcox JN (2001) Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery. Circulation 104(14): 1591–1593
Wilcox JN, Scott NA (1996) Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 54(Suppl): S21–35
Wilcox JN, Cipolla GD, Martin FH, Simonet L, Dunn B, Ross CE, Scott NA (1997) Contribution of adventitial myofibroblasts to vascular remodeling and lesion formation after experimental angioplasty in pig coronary arteries. Ann NY Acad Sci 811: 437–447
Wilcox JN, Waksman R, King SB, Scott NA (1996) The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys 36(4): 789–796
Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN (1996) Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93(12): 2178–2187
Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J (2001) Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann NY Acad Sci 947: 68–90; discussion 90–92
Clowes AW, Reidy MA, Clowes MM (1983) Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49(3): 327–333
Clowes AW, Clowes MM, Fingerle J, Reidy MA (1989) Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. Lab Invest 60(3): 360–364
Fingerle J, Au YP, Clowes AW, Reidy MA (1990) Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 10(6):1082–1087
Lindner V, Fingerle J, Reidy MA (1993) Mouse model of arterial injury. Circ Res 73(5):792–796
Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED (2000) Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 20(2): 335–342
Fishman JA, Ryan GB, Karnovsky MJ (1975) Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 32(3): 339–351
Chen Z, Sakuma M, Zago AC, Zhang X, Shi C, Leng L, Mizue Y, Bucala R, Simon D (2004) Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 24(4): 709–714
Kuhel DG, Zhu B, Witte DP, Hui DY (2002) Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler Thromb Vasc Biol 22(6): 955–960
Harmon KJ, Couper LL, Lindner V (2000) Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol 156(5): 1741–1748
Manka DR, Wiegman P, Din S, Sanders JM, Green SA, Gimple LW, Ragosta M, Powers ER, Ley K, Sarembock IJ (1999) Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice. J Vasc Res 36(5): 372–378
Manka D, Collins RG, Ley K, Beaudet AL, Sarembock IJ (2001) Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice. Circulation 103(7): 1000–1005
Quarck R, De Geest B, Stengel D, Mertens A, Lox M, Theilmeier G, Michiels C, Raes M, Bult H, Collen D et al (2001) Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation 103(20): 2495–2500
Schober A, Bernhagen J, Thiele M, Zeiffer U, Knarren S, Roller M, Bucala R, Weber C (2004) Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109(3): 380–385
Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, Weber C (2004) Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res 95(11): 1125–1133
Shi W, Pei H, Fischer JJ, James JC, Angle JF, Matsumoto AH, Helm GA, Sarembock IJ (2004) Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility. J Lipid Res 45(11): 2008–2014
Schulze PC, de Keulenaer GW, Kassik KA, Takahashi T, Chen Z, Simon DI, Lee RT (2003) Biomechanically induced gene iex-1 inhibits vascular smooth muscle cell proliferation and neointima formation. Circ Res 93(12): 1210–1217
Reis ED, Roque M, Dansky H, Fallon JT, Badimon JJ, Cordon-Cardo C, Shiff SJ, Fisher EA (2000) Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 97(23): 12764–12769
Kumar A, Lindne V (1997), Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17(10): 2238–2244
Berguer R, Higgins RF, Reddy DJ (1980) Intimal hyperplasia. An experimental study. Arch Surg 115(3): 332–335
Dobrin PB, Littooy FN, Endean ED (1989) Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 105(3): 393–400
Kraiss LW, Kirkman TR, Kohler TR, Zierler B, Clowes AW (1991) Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler Thromb 11(6): 1844–1852
Kohler TR, Kirkman TR, Kraiss LW, Zierler BK, Clowes AW (1991) Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. Circ Res 69(6):1557–1565
Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK (2000) Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102(14): 1697–1702
Korshunov VA, Berk BC (2003) Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol 23(12):2185–2191
Sullivan CJ, Hoying JB (2002) Flow-dependent remodeling in the carotid artery of fibroblast growth factor-2 knockout mice. Arterioscler Thromb Vasc Biol 22(7):1100–1105
Dimayuga P, Zhu J, Oguchi S, Chyu KY, Xu XO, Yano J, Shah PK, Nilsson J, Cercek B (1999) Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice. Biochem Biophys Res Commun 264(2): 465–468
von der Thusen JH, van Berkel TJ, Biessen EA (2001) Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103(8): 1164–1170
Wu L, Iwai M, Nakagami H, Li Z, Chen R, Suzuki J, Akishita M, de Gasparo M, Horiuchi M (2001) Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104(22): 2716–2721
Liu HW, Iwai M, Takeda-Matsubara Y, Wu L, Li JM, Okumura M, Cui TX, Horiuchi M (2002) Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension 40(4): 451–457; discussion 448–450
Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, Quax PH, Lim SK, Borst C, Pasterkamp G, de Kleijn DP (2002) In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106(15):1985–1990
Chyu KY, Dimayuga P, Zhu J, Nilsson J, Kaul S, Shah PK, Cercek B (1999) Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res 85(12): 1192–1198
Moroi M, Izumida T, Morita T, Tatebe J, Ishii C, Imai T, Yagi S, Yamaguchi T, Katayama S (2003) Effect of p53 deficiency on external vascular cuff-induced neointima formation. Circ J 67(2): 149–153
von der Thusen JH, van Vlijmen BJ, Hoeben RC, Kockx MM, Havekes LM, van Berkel TJ, Biessen EA (2002) Induction of atherosclerotic plaque rupture in apolipoprotein E-/-mice after adenovirus-mediated transfer of p53. Circulation 105(17): 2064–2070
von der Thusen JH, Kuiper J, Fekkes ML, de Vos P, van Berkel TJ, Biessen EA (2001) Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 15(14): 2730–2732
Patel SS, Thiagarajan R, Willerson JT, Yeh ET (1998) Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoEdeficient mice. Circulation 97(1): 75–81
Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler hromb 14(1): 133–140
Aicher A, Heeschen C, Mohaupt M, Cooke JP, Zeiher AM, Dimmeler S (2003) Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 107(4): 604–611
Kim CJ, Khoo JC, Gillotte-Taylor K, Li A, Palinski W, Glass CK, Steinberg D (2000) Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tumor necrosis factor-alpha and interleukin-1 beta. Arterioscler Thromb Vasc Biol 20(8): 1976–1982
van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM (2002) Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein AI mimetic peptide. Circulation 106(9): 1127–1132
Navab M, Anantharamaiah GM, Reddy ST, van Lenten BJ, Hough G, Wagner A, Naka-mura K, Garber DW, Datta G, Segrest JP (2003) Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis. Curr Opin Investig Drugs 4(9): 1100–1104
Madjid M, Naghavi M, Malik BA, Litovsky S, Willerson JT, Casscells W (2002) Thermal detection of vulnerable plaque. Am J Cardiol 90(10C): 36L–39L
Verheye S, de Meyer GR, van Langenhove G, Knaapen MW, Kockx MM (2002) In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation 105(13): 1596–1601
Pasterkamp G, Falk E (2000) Atherosclerotic plaque rupture: An overview. J Clin Basic Cardiol 3(2): 81–86
Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM (2000) Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 20(12): 2587–2592
Johnson JL, Jackson CL (2001) Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 154(2): 399–406
Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, Keiser JA, Ryan MJ (1998) Animal model that mimics atherosclerotic plaque rupture. Circ Res 83(7): 705–713
Rekhter MD, Hicks GW, Brammer DW, Hallak H, Kindt E, Chen J, Rosebury WS, Anderson MK, Kuipers PJ, Ryan MJ (2000) Hypercholesterolemia causes mechanical weakening of rabbit atheroma: local collagen loss as a prerequisite of plaque rupture. Circ Res 86(1): 101–108
Rekhter M (2002) Vulnerable atherosclerotic plaque: emerging challenge for animal models. Curr Opin Cardiol 17(6): 626–632
Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A (1999) Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99(16): 2079–2084
Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101(18): 2149–2153
Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94(5): 874–877
Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331(7): 417–424
Andrassy M, Belov D, Harja E, Zou YS, Leitges M, Katus HA, Nawroth PP, Yan SD, Schmidt AM, Yan SF (2005) Central role of PKCbeta in neointimal expansion triggered by acute arterial injury. Circ Res 96(4): 476–483
Hutter R, Sauter BV, Reis ED, Roque M, Vorchheimer D, Carrick FE, Fallon JT, Fuster V, Badimon JJ (2003) Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation 107(12):1658–1663
Hofmann CS, Sullivan CP, Jiang HY, Stone PJ, Toselli P, Reis ED, Chereshnev I, Schreiber BM, Sonenshein GE (2004) B-Myb represses vascular smooth muscle cell collagen gene expression and inhibits neointima formation after arterial injury. Arterioscler Thromb Vasc Biol 24(9): 1608–1613
Zhu B, Reardon CA, Getz GS, Hui DY (2002) Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol 22(3): 450–455
de Geest B, Zhao Z, Collen D, Holvoet P (1997) Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo Edeficient mice. Circulation 96(12): 4349–4356
Chen Z, Fukutomi T, Zago AC, Ehlers R, Detmers PA, Wright SD, Rogers C, Simon DI (2002) Simvastatin reduces neointimal thickening in low-density lipoprotein receptordeficient mice after experimental angioplasty without changing plasma lipids. Circulation 106(1): 20–23
Simon DI, Dhen Z, Seifert P, Edelman ER, Ballantyne CM, Rogers C (2000) Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest 105(3): 293–300
Kawasaki T, Dewerchin M, Lijnen HR, Vreys I, Vermylen J, Hoylaerts MF (2001) Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development. Circ Res 88(2): 159–166
Li Y, Minamino T, Tsukamoto O, Yujiri T, Shintani Y, Okada K, Nagamachi Y, Fujita M, Hirata A, Sanada S et al (2005) Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model. Circulation 111(13): 1672–1678
Jonsson-Rylander AC, Nilsson T, Fritsche-Danielson R, Hammarstrom A, Behrendt M, Andersson JO, Lindgren K, Andersson AK, Wallbrandt P, Rosengren B et al (2005) Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 25(1): 180–185
Hassan GS, Jasmin JF, Schubert W, Frank PG, Lisanti MP (2004) Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43(26):8312–8321
Khatri JJ, Johnson C, Magid R, Lessner SM, Laude KM, Dikalov SI, Harrison DG, Sung HJ, Rong Y, Galis ZS (2004) Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109(4): 520–525
Tran PK, Tran-Lundmark K, Soininen R, Tryggvason K, Thyberg J, Hedin U (2004) Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ Res 94(4): 550–558
Kuzuya M, Kanda S, Sasaki T, Tamaya-Mori N, Cheng XW, Itoh T, Itohara S, Iguchi A (2003) Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 108(11): 1375–1381
Singh R, Pan S, Mueske CS, Witt TA, Kleppe LS, Peterson TE, Caplice NM, Simari RD (2003) Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling. Thromb Haemost 89(4): 747–751
Singh R, Pan S, Mueske CS, Witt T, Kleppe LS, Peterson TE, Slobodova A, Chang JY, Caplice NM, Simari RD (2001) Role for tissue factor pathway in murine model of vascular remodeling. Circ Res 89(1): 71–76
Qin F, Impeduglia T, Schaffer P, Dardik H (2003) Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. J Vasc Surg 37(2): 433–439
Squadrito F, Deodato B, Bova A, Marini H, Saporito F, Calo M, Giacca M, Minutoli L, Venuti FS, Caputi AP, Altavilla D (2003) Crucial role of nuclear factor-kappaB in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow. Atherosclerosis 166(2): 233–242
Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E (2002) Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 91(9): 852–859
Cho A, Reidy MA (2002) Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91(9):845–851
Murakoshi N, Miyauchi T, Kakinuma Y, Ohuchi T, Goto K, Yanagisawa M, Yamaguchi I (2002) Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation 106(15) 1991–1998
Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ (1997) Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation 96(12): 4333–4342
Bryant SR, Bjercke RJ, Erichsen DA, Rege A, Lindner V (1999) Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. Circ Res 84(3):323–328
Bot I, von der Thusen JH, Donners MM, Lucas A, Fekkes ML, de Jager SC, Kuiper J, Daemen MJ, van Berkel TJ, Heeneman S, Biessen EA (2003) Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. Circ Res 93(5): 464–471
Oguchi S, Dimayuga P, Zhu J, Chyu KY, Yano J, Shah PK, Nilsson J, Cercek B (2000) Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 20(7): 1729–1736
de Nooijer R, von der Thusen JH, Verkleij CJ, Kuiper J, Jukema JW, van der Wall EE, van Berkel JC, Biessen EA (2004) Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol 24(12): 2313–2319
Lardenoye JH, Delsing DJ, de Vries MR, Deckers MM, Princen HM, Havekes LM, van Hinsbergh VW, van Bockel JH, Quax PH (2000) Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice. Circ Res 87(3): 248–253
Imai Y, Shindo T, Maemura K, Sata M, Saito Y, Kurihara Y, Akishita M, Osuga J, Ishibashi S, Tobe K et al (2002) Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression. Arterioscler Thromb Vasc Biol 22(8): 1310–1315
Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M, Tada N, Ohsuzu F (2002) Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 91(1): 77–82
Chen X, Li Z, Li J (2002) Anti-inflammatory effect of cerivastatin in vascular injury independent of serum cholesterol and blood pressure lowering effects in mouse model. Chin J Traumatol 5(5): 294–298
Isoda K, Shiigai M, Ishigami N, Matsuki T, Horai R, Nishikawa K, Kusuhara M, Nishida Y, Iwakura Y, Ohsuzu F (2003) Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation 108(5): 516–518
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Kalmes, H.A., Toombs, C.F. (2006). Preclinical models of vascular inflammation. In: Stevenson, C.S., Marshall, L.A., Morgan, D.W. (eds) In Vivo Models of Inflammation. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7760-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-7643-7760-1_7
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7757-1
Online ISBN: 978-3-7643-7760-1
eBook Packages: MedicineMedicine (R0)